Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study ; day:24 ; month:2 ; year:2016 ; pages:1-9
Breast cancer research and treatment ; (24.2.2016), 1-9
- Creator
-
Martin, Miguel
- Contributor
-
Brase, Jan C.
Ruiz, Amparo
Prat, Aleix
Kronenwett, Ralf
Calvo, Lourdes
Petry, Christoph
Bernard, Philip S.
Ruiz-Borrego, Manuel
Weber, Karsten E.
Rodriguez, César A.
Alvarez, Isabel M.
Segui, Miguel A.
Perou, Charles M.
Casas, Maribel
Carrasco, Eva
Caballero, Rosalía
Rodriguez-Lescure, Alvaro
SpringerLink (Online service)
- DOI
-
10.1007/s10549-016-3725-z
- URN
-
urn:nbn:de:1111-201602253610
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Martin, Miguel
- Brase, Jan C.
- Ruiz, Amparo
- Prat, Aleix
- Kronenwett, Ralf
- Calvo, Lourdes
- Petry, Christoph
- Bernard, Philip S.
- Ruiz-Borrego, Manuel
- Weber, Karsten E.
- Rodriguez, César A.
- Alvarez, Isabel M.
- Segui, Miguel A.
- Perou, Charles M.
- Casas, Maribel
- Carrasco, Eva
- Caballero, Rosalía
- Rodriguez-Lescure, Alvaro
- SpringerLink (Online service)
Other Objects (12)
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
Budget Impact of the Oncotype DX Breast Recurrence Score ® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy
The prognostic significance of lymph node size in node-positive colon cancer
The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
Budget Impact of the Oncotype DX Breast Recurrence Score ® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy
The prognostic significance of lymph node size in node-positive colon cancer
The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer
Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
Budget Impact of the Oncotype DX Breast Recurrence Score ® Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer
Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy
The prognostic significance of lymph node size in node-positive colon cancer
The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
A tailored approach in lymph node-positive perihilar cholangiocarcinoma
Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer
Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy